Provectus Pharmaceuticals faculty Present at the 2012 Maxim Group Growth ... EON: Enhanced Online tidings (press release) Its medicine drug PH-10 also targets abnormal or diseased cells, with the current focussing on psoriasis and atopic dermatitis. Provectus has lately completed Phase 2 trials of PV-10 as type A therapy for metastatic melanoma, and of PH-10 As a topical ... and more » Link To Article
No comments:
Post a Comment